Status:

RECRUITING

Cryoneurolysis for Acute Postoperative Pain Following Total Knee Arthroplasty

Lead Sponsor:

Copenhagen University Hospital, Hvidovre

Collaborating Sponsors:

Rigshospitalet, Denmark

Conditions:

Acute Postoperative Pain

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Cryoneurolysis is a regional anaesthetic technique that works by freezing peripheral sensory nerves. This technique can potentially provide analgesia after total knee arthroplasty (TKA). However, the ...

Detailed Description

Background Total knee arthroplasty (TKA) is a frequently performed procedure and is expected to increase in numbers due to the aging population and growing obesity rates. Fast-track regimes with multi...

Eligibility Criteria

Inclusion

  • Age ≥ 18
  • Primary unilateral total knee arthroplasty
  • Ability to participate in the study (understand written and spoken Danish language, self-reported pain and satisfaction)
  • Signed written informed consent form
  • Pain (VAS 0-100 mm) ≥ 45 during a 5-meter walk test at 24 h (20-28h) postoperatively

Exclusion

  • Ongoing treatment of systemic glucocorticoids or other immunosuppressant treatment apart from inhaled steroids
  • Insulin-dependent diabetes
  • Pregnancy or breastfeeding
  • Mental disability that could impair a patient's decision-making capability of giving informed consent and not enabling valid data collection.
  • Patients with known diagnoses of schizophrenia, ongoing psychosis, bipolar disease and/or a history of ongoing anti-psychotic treatment.
  • Patients with modulated pain-reception (experience) based on other diseases or injuries, e.g. spinal cord or brain injury, severe polyneuropathies or neurologic disorders.
  • Posttraumatic osteoarthritis as reason for total knee arthroplasty
  • Bleeding disorder
  • Localized infection in the treatment area
  • Cryoglobulinemia, cold urticaria, paroxysmal cold haemoglobinuria, or Raynaud's syndrome
  • Perioperative peripheral nerve block

Key Trial Info

Start Date :

March 19 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2025

Estimated Enrollment :

44 Patients enrolled

Trial Details

Trial ID

NCT06088602

Start Date

March 19 2024

End Date

October 1 2025

Last Update

July 16 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hvidovre Hospital

Hvidovre, Denmark, 2650